LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)
Hong Kong
· Delayed Price · Currency is HKD 11.72
+0.04 (0.34%)
Apr 29, 2026, 4:08 PM HKT
HKG:2291 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Net Income | - | 245.56 | 151.38 | -19.81 | 58.7 | Upgrade
|
| Depreciation & Amortization | - | 21.33 | 6.01 | 14.87 | 9.81 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0 | 0 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | 10.66 | -0.53 | Upgrade
|
| Stock-Based Compensation | - | - | - | 20.51 | 17.8 | Upgrade
|
| Other Operating Activities | - | -44.41 | 6.87 | 88.04 | 5.67 | Upgrade
|
| Change in Accounts Receivable | - | - | - | -12.03 | 13.51 | Upgrade
|
| Change in Inventory | - | - | - | -24 | -10.08 | Upgrade
|
| Change in Accounts Payable | - | - | - | 7.92 | 9.25 | Upgrade
|
| Change in Unearned Revenue | - | - | - | -1.66 | -0.56 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | -18.96 | 1.73 | Upgrade
|
| Operating Cash Flow | - | 222.49 | 164.26 | 65.53 | 105.28 | Upgrade
|
| Operating Cash Flow Growth | - | 35.45% | 150.66% | -37.75% | 78.14% | Upgrade
|
| Capital Expenditures | - | -85.44 | -97.51 | -13.28 | -22.45 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -70.08 | -69.39 | Upgrade
|
| Investment in Securities | - | -40.65 | 198.06 | -252.64 | 6.67 | Upgrade
|
| Other Investing Activities | - | 8.87 | 10.76 | -70 | - | Upgrade
|
| Investing Cash Flow | - | -117.22 | 111.32 | -406 | -85.17 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -3.63 | -2.38 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -3.63 | -2.38 | Upgrade
|
| Issuance of Common Stock | - | - | - | 601.63 | 661.02 | Upgrade
|
| Common Dividends Paid | - | -194.77 | - | - | -320 | Upgrade
|
| Other Financing Activities | - | -2.14 | -2.05 | -20.2 | 333.58 | Upgrade
|
| Financing Cash Flow | - | -196.91 | -2.05 | 577.8 | 672.23 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.94 | -6.01 | -6.3 | 2.36 | Upgrade
|
| Net Cash Flow | - | -90.7 | 267.52 | 231.04 | 694.69 | Upgrade
|
| Free Cash Flow | - | 137.05 | 66.75 | 52.25 | 82.83 | Upgrade
|
| Free Cash Flow Growth | - | 105.32% | 27.75% | -36.92% | 46.41% | Upgrade
|
| Free Cash Flow Margin | - | 29.06% | 20.44% | 21.10% | 37.21% | Upgrade
|
| Free Cash Flow Per Share | - | 0.40 | 0.19 | 0.16 | 0.27 | Upgrade
|
| Cash Income Tax Paid | - | 81.73 | 61.27 | 4.72 | 0.52 | Upgrade
|
| Levered Free Cash Flow | - | 96.94 | -6.58 | -707.51 | 646 | Upgrade
|
| Unlevered Free Cash Flow | - | 97.04 | -6.49 | -695.65 | 653.22 | Upgrade
|
| Change in Working Capital | - | - | - | -48.73 | 13.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.